{
  "main_header": {
    "sid": 905552,
    "name": "Anuh Pharma",
    "stock_name": "Anuh Pharma",
    "full_name": "Anuh Pharma Ltd",
    "name_url": "stocks-analysis/anuh-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "81.50",
    "chg": -0.46,
    "chgp": "-0.56%",
    "dir": -1,
    "prev_price": "81.96",
    "mcapval": "818.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 506260,
    "symbol": "ANUHPHR",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE489G01022",
    "curr_date": "Oct 09",
    "curr_time": "",
    "bse_nse_vol": "43.9 k",
    "exc_status": "Active",
    "traded_date": "Oct 09, 2026",
    "traded_date_str": "2026 10 09",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/anuh-pharma-905552-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 1,
    "sid": "905552",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/anuh-pharma-905552"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "28-Sep-2026",
      "details": "Intimation regarding the closure of Trading Window for dealing in Securities of the Company shall remain closed from Thursday 01st October 2026 till the expiry of 48 hours after the declaration of Unaudited Financial Results for the quarter and half year ended 30th September 2026.",
      "source": "BSE"
    },
    {
      "caption": "Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI LODR)",
      "datetime": "18-Sep-2026",
      "details": "Disclosure under Regulation 30 of the SEBI LODR regarding receipt of Demand Order under Section 156 of the Income Tax Act 1961.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
      "datetime": "19-Aug-2026",
      "details": "Investor Presentation for Q1 FY 2026-27",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Anuh Pharma Ltd has declared <strong>30%</strong> dividend, ex-date: 05 Aug 26",
          "dt": "2026-08-05",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Anuh Pharma Ltd has announced <strong>5:10</strong> stock split, ex-date: 31 Jul 06",
          "dt": "2006-07-31",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Anuh Pharma Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 15 Jul 25",
          "dt": "2025-07-15",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

No Recent News for the Company

View All News